2020 (162 POSTS)
Levin-Sparenberg E, Bylsma LC , Lowe K, Sangare L, Fryzek JP, Alexander DD. 2020. A systematic literature review and meta-analysis describing the prevalence of KRAS, NRAS, and BRAF gene mutations in metastatic colorectal cancer. Gastroenterol Res 13(5):184–198; doi: 10.14740/gr1167 . PMID: 33224365.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , meta-analysis , Systematic Review
Suh M , Movva N , Fryzek J, Bylsma L , Rizzo C, Nelson CB. Systematic literature review of historical and current respiratory syncytial virus (RSV) clinical testing policy and practice in the United States. IDWeek Virtual Conference on Infectious Disease, October 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Epidemiology , Systematic Review
Suh M , Movva N , Fryzek J, Bylsma L , Demont C, Rizzo C, Nelson CB. Systematic literature review of respiratory syncytial virus (RSV) burden and RSV clinical sequelae among infants and children up to 5 years of age living in the United States. IDWeek Virtual Conference on Infectious Disease, October 2020.
View Abstract
Publication: Abstracts and Presentations
/ Topics: Epidemiology , Systematic Review
Whaley P, Aiassa E, Beausoleil C, Beronius A, Bilotta, G, Boobis A, de Vries R,… , Wikoff D , et al. 2020. Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER). Environ Int 143(Oct):105926; doi: 10.1016/j.envint.2020.105926 . PMID: 32653802.
View Abstract
Publication: Manuscripts
/ Topics: Systematic Review
Fergie J, Gonzales T, Suh M , Jiang X , Fryzek J, Howard A, Bloomfield A. Medically attended respiratory syncytial virus hospitalizations (RSVH) and all-cause bronchiolitis hospitalizations (BH) among children aged ≤24 months at RSV season start with higher-risk congenital heart disease (CHD) before and after the 2014 American Academy of Pediatrics (AAP) policy. Presentation to IDWeek Conference on Infectious Disease, Virtual, October 2020.
Publication: Abstracts and Presentations
/ Topics: Epidemiology
House JS, Grimm FA, Klaren WD , Dalzell A, Kuchi S, Zhang S, Lenz K, Boogaard PJ, et al. 2020. Grouping of UVCB substances with new approach methodologies (NAMs) data. ALTEX 38(1):123–137; doi: 10.14573/altex.2006262 . PMID: 33086383.
View Abstract
Publication: Manuscripts
/ Topics: NAMs
Flythe JE, Hilliard TS, Ikeler K, Keller S, Gipson DS, Grandinetti AC, Nordyke RJ , Perrone RD, et al. 2020. Toward patient-centered innovation: A conceptual framework for patient-reported outcome measures for transformative kidney replacement devices. Clin J Am Soc Nephrol 15(10):1522-1530; doi: 10.2215/CJN.00110120 . PMID: 32276947.
View Abstract
Publication: Manuscripts
/ Topics: Health Economics and Outcomes Research (HEOR)
Guo X, Seo JE, Petibone D, Tryndyak V, Lee UJ, Zhou T, Robison TW , Mei N. 2020. Performance of HepaRG and HepG2 cells in the high-throughput micronucleus assay for in vitro genotoxicity assessment. J Toxicol Environ Health A 83(21-22):702-717; doi: 10.1080/15287394.2020.1822972 .
View Abstract
Publication: Manuscripts
/ Topics: benchmark dose estimation (BMD) , mode of action
Brown L , Lynch M, Belova A, Klein R, Chiger A. 2020. Developing a health impact model for adult lead exposure and cardiovascular disease mortality. Environ Health Persp 128(9):97005; doi: 10.1289/EHP6552 . PMID: 32965128.
View Abstract
Publication: Manuscripts
/ Topics: lead
Jackson AC, Liu J, Vallanat B, Jones C, Nelms MD, Patlewicz G , Corton JC. 2020. Identification of novel activators of the metal responsive transcription factor (MTF-1) using a gene expression biomarker in a microarray compendium. Metallomics 12(9):1400-1415; doi: 10.1039/d0mt00071j . PMID: 32661532.
View Abstract
Publication: Manuscripts
/ Topics: Metals
Wheeler MW , Blessinger T, Shao K, Allen BC, Olszyk L, Davis JA, Gift JS. 2020. Quantitative risk assessment: Developing a Bayesian approach to dichotomous dose–response uncertainty. Risk Anal 40(9):1706-22; doi: 10.1111/risa.13537 . PMID: 32602232.
View Abstract
Publication: Manuscripts
/ Topics: Bayesian modeling , benchmark dose estimation (BMD) , dose-response , risk assessment
Kieran TJ, Goodman SJ , Finger JW Jr, Thomas JC 4th , Hamilton MT, Tuberville TD, Glenn TC. 2020. Microbiota of four tissue types in American alligators (Alligator mississippiensis ) following extended dietary selenomethionine exposure. Bull Environ Contam Toxicol 105(3):381-386; doi: 10.1007/s00128-020-02961-3 . PMID: 32794125.
View Abstract
Publication: Manuscripts
/ Topics: Exposure Assessment , food safety , Food science
Parker J, Boles C, Leleck O, Buerger AN , Egnot N, Sunderman A, et al. 2020. Advancing toward normal operations for arenas and stadiums. Toxicol Ind Health 36(9):718–727; doi: 10.1177/0748233720964651 . PMID: 33030104.
View Abstract
Publication: Manuscripts
/ Topics: COVID-19
Bell S, Abedini J, Ceger P, Chang X, Cook B, Karmaus AL, Lea I , Mansouri K, et al. 2020. An integrated chemical environment with tools for chemical safety testing. Toxicol in Vitro 67(Sept):104916; doi: 10.1016/j.tiv.2020.104916 . PMID: 32553663.
View Abstract
Publication: Manuscripts
/ Topics: chemical safety assessment
Bhat VS, Cohen SM, Gordon EB, Wood CE, Cullen JM, Harris MA, Proctor DM , Thompson CM . 2020. An adverse outcome pathway for small intestinal tumors in mice involving chronic cytotoxicity and regenerative hyperplasia: A case study with hexavalent chromium, captan, and folpet. Crit Rev Toxicol 50(8)685-706; doi: 10.1080/10408444.2020.1823934 . PMID: 33146058.
View Abstract
Publication: Manuscripts
/ Topics: Adverse outcome pathways (AOPs) , chromium
Li S, Peng Y, Liu J, Li S, Raskin L, Kelsh MA , et al. 2020. Variations in hospitalization and emergency department/observation stays using the oncology care model methodology in Medicare data. Curr Med Res Opin 36(9):1519–1527; doi: 10.1080/03007995.2020.1801403 . PMID: 32715807.
View Abstract
Publication: Manuscripts
/ Topics: Cancer
Gawade PL, Li S, Henry D, Smith N, Belani R, Kelsh MA , et al. 2020. Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy. Support Care Cancer 28(9):4413–4424; doi: 10.1007/s00520-020-05295-2 . PMID: 31919669.
View Abstract
Publication: Manuscripts
/ Topics: Cancer
Locatelli F, Whitlock JA, Peters C, Chen-Santel C, Chia V, Dennis RM, … Kelsh MA , et al. 2020. Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia. Leukemia 34(9):2473–2478; doi: 10.1038/s41375-020-0770-8 . PMID: 32094465.
View Abstract
Publication: Manuscripts
/ Topics: Cancer , Epidemiology
Fryzek J, Bylsma L , Mease K , Movva N , Welsh BT, Wood M . 2020. Critical insights into nonclinical toxicology and real-world evidence essential for a successful rare disease product launch. EpidStrategies, Inc. White Paper .
View Abstract
Publication: White paper
/ Topics: nonclinical safety assessment
Liu S, Refaei M, Liu S, Decker A, Hinerman JM , Herr AB, Howell M, Musier-Forsyth K, Tsang P. 2020. Hairpin RNA-induced conformational change of a eukaryotic-specific lysyl-tRNA synthetase extension and role of adjacent anticodon-binding domain. J Biol Chem 295(34):12071–12085; doi: 10.1074/jbc.RA120.013852 . PMID: 32611767.
View Abstract